Clinical Trials
61 trialsSafety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Tactical Therapeutics, Inc.
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
Shanghai Simnova Biotechnology Co.,Ltd.
POBIG
The Christie NHS Foundation Trust
MIRROR
University Medical Center Groningen
PREHABILITA
Institut Guttmann
OKN-007
Oblato, Inc.
Phase 1 Study of BCD-245 in Subjects With Neuroblastoma
Biocad
Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab
Second Affiliated Hospital, School of Medicine, Zhejiang University
Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
OX2 Therapeutics
Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
University of Louisville
A Clinical Study of IL13Rα2 Targeted CAR-T in Patients With Malignant Glioma (MAGIC-I)
CellabMED
Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
ImmVira Pharma Co. Ltd
TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma
PharmAbcine
Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
Global Neurosciences Institute
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
South Plains Oncology Consortium
Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma
Ruijin Hospital
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
Fudan University
Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
Royan Institute
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
CARTREMENDOUS
Chembrain LTD
Personalized Vaccine for Patients With Recurrent Malignant Glioma
Xuanwu Hospital, Beijing
Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas
Xuanwu Hospital, Beijing
Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors
Kunming Pharmaceuticals, Inc.
HUTMZ
Amsterdam UMC, location VUmc
NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
HMPL-813 in Treating Patients With Glioblastoma
Hutchmed
Immune Modulatory DC Vaccine Against Brain Tumor
Shenzhen Geno-Immune Medical Institute
Cytoprotective Effect and Clinical Outcome of Perioperative Proesterone in Brain Tumors
Minia University
Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles.
Genor Biopharma Co., Ltd.
InSituVac1
Beijing Tiantan Hospital
A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
Leaf Vertical Inc.
Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer
Northwest Biotherapeutics
MARELLE01
Assistance Publique Hopitaux De Marseille
Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
University of Virginia
Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma
National Cancer Institute (NCI)
Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines
Fundació Sant Joan de Déu
SMC 0712-13
Sheba Medical Center
Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial
National Taiwan University Hospital
Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme
Beijing Sanbo Brain Hospital
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
Shenzhen Second People's Hospital
Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme
Beijing Sanbo Brain Hospital
TKI258
University Hospital, Bonn
Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors
Massachusetts General Hospital
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
European Organisation for Research and Treatment of Cancer - EORTC
Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas
European Organisation for Research and Treatment of Cancer - EORTC
CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR
RenJi Hospital
Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery
Assaf-Harofeh Medical Center
IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma
National Cancer Institute (NCI)